Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2010
09/28/2010US7803749 Prevent signal transduction passageways; kinase inhibitor; modulate immunology response
09/28/2010US7803739 Substrates and assays for β-secretase
09/28/2010US7803623 Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate
09/28/2010US7803622 Adeno-associated virus vectors
09/28/2010US7803621 Plasmid comprised of viral envelope protein for use as nucleic acid transfer tool in gene therapeutic; safe and high-efficiency vector for in-vitro and in-vivo gene transfer; drug delivery systems; for gene therapy and high throughput screening
09/28/2010US7803620 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms Shewanella japonica and Shewanella olleyana; plants and microorganisms that produce lipids
09/28/2010US7803618 nucleic acid encoding an anti-EpCAM protein; binds human epithelial cell adhesion molecule; immunoglobulin light chain region modified to reduce immunogenicity; diagnosis, prognosis and treatment of cancer
09/28/2010US7803617 Conditional gene vectors regulated in cis
09/28/2010US7803615 Death domain containing receptor 5
09/28/2010US7803614 isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevent and treatment; immunotherapy
09/28/2010US7803612 Nipah virus vaccines
09/28/2010US7803611 RNAi expression constructs
09/28/2010US7803605 yeast having thermotolerance; obtained by controlling proofreading function of DNA polymerase in a loss-of-function mutant of yeast such as a gene-disruptant of yeast; produces beta-glucan efficiently
09/28/2010US7803604 Amylolytic enzyme extracted from Bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme
09/28/2010US7803603 Nematode ATP synthase subunit E polypeptide
09/28/2010US7803602 Method for overexpression of zwitterionic polysaccharides
09/28/2010US7803601 Production and secretion of glucose in photosynthetic prokaryotes (cyanobacteria)
09/28/2010US7803598 CGTase polypeptide with increased hydrolase activity; useful in preparing a food or a food product such as bakery products
09/28/2010US7803597 Thermally-tolerant pectin methylesterase
09/28/2010US7803595 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/28/2010US7803594 Recombinant arginine methyltransferase encoded by nucleic acid sequences of Trypanosoma brucei
09/28/2010US7803593 Nucleic acid molecule that encodes the MGAT-X1 protein; pharmaceutical composition containing the nucleic acid or its expression vector
09/28/2010US7803592 Substrate specificity for glucose is improved by substituting another amino acid residue for the amino acid residue at position 472 and/or 475; sensors, assay kits
09/28/2010US7803591 Polynucleotide coding for a multimeric oxidoreductase complex having an alpha subunit, a gamma subunit and a cytochrome C subunit with specific amino acid sequences; used to manufacture of L-ascorbic acid
09/28/2010US7803584 Cultivating an Escherichia coli that has been modified to attenuate expression of the sraL gene and collecting L-threonine and/or L-lysine from the medium
09/28/2010US7803579 Strand displacement amplification is used to synthesize a nucleic acid having a sequence complementary to a target sequence by using a primer designed so that it is capable of forming a stem-loop structure by the extension of the primer and satisfies additional specific requirements
09/28/2010US7803578 A gene encoding a protein having an improved nitrile hydratase activity, whereby heat resistance has been improved or substrate specificity has been changed; for efficient production of acrylamide
09/28/2010US7803577 Polynucleotide encoding a tropoelastin polypeptide; expression products and hybrid molecules of the derivatives and variants
09/28/2010US7803576 Nucleic acid sequences encoding VEGF-like factors and uses thereof
09/28/2010US7803564 EGF-like nucleic acids and polypeptides and uses thereof
09/28/2010US7803562 Method for screening human intestinal Npt2B modulatory agents
09/28/2010US7803560 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist
09/28/2010US7803553 Detecting the activation reactions of human transforming growth factor- beta 1, 2, and/or 3 in samples by staining or reacting the sample with an antibody against a latency-associated peptide fragment of human TGF- beta , that recognizes a protease cleavage site; diagnosing sclerotic diseases
09/28/2010US7803547 Using primer amplification to identify lepidopteran insect resistant cotton; biological pest control
09/28/2010US7803532 Diagnosis of Sezary syndrome (a type of lymphoma) by analyzing a nucleic acid sample from a human patient to detect the presence or the absence of a neuron navigator 3 gene and diagnosing Sezary syndrome when the gene is absent
09/28/2010US7803531 Anticancer, antitumor agents
09/28/2010US7803530 Detection and typing of human papillomavirus using PNA probes
09/28/2010US7803524 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates
09/28/2010US7803405 Vesicle encapsulating an aqueous system of a polymer and can exist as more than one phase depending on temperature and composition
09/28/2010US7803399 Delivery system for nucleic acids
09/28/2010US7803389 Toxoplasma gondii mutant with enhanced homologous recombination and uses thereof
09/28/2010US7803387 With proteins of nisseria and purification of domains and gene expression of oligopeptides of ser, lys, ala, glu, gly and met
09/28/2010US7803379 Tumour-specific animal proteins
09/28/2010US7803378 Antigen imitating extracellular areas of membrane proteins of type III produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof
09/28/2010US7803373 Chemokine panec-1 antibodies
09/28/2010US7803365 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
09/28/2010US7803361 Decreasing solid tumor size in a cancer patient by administering an interleukin-2 mutant with reduced vasopermeability activity compared to a wildtype form, and being Arg38Trp, wherein said wildtype form is human IL-2 mutant and the IL-2 mutant is not linked to an antibody.
09/28/2010CA2479935C Compositions and methods for altering tocotrienol content
09/28/2010CA2422685C Stress-induced promoter derived from rice
09/28/2010CA2422620C Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome p450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene
09/28/2010CA2415493C Cation mediated triplex hybridization assay
09/28/2010CA2407726C Sulfonated [8,9]benzophenoxazine dyes and the use of their labelled conjugates
09/28/2010CA2407124C Denaturant-free electrophoresis of biological molecules under high temperature conditions
09/28/2010CA2404471C A construct capable of release in closed circular form from a larger nucleotide sequence permitting site specific expression and/or developmentally regulated expression of selected genetic sequences
09/28/2010CA2382631C Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids
09/28/2010CA2380298C Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
09/28/2010CA2371994C Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
09/28/2010CA2326821C Nucleic acid encoding hyaluronan synthase and methods of use
09/28/2010CA2323503C Novel physiological active peptide and its use
09/28/2010CA2286288C Monoclonal antibody recognizing the n-glycolylated-galacotose-glucose sialic acid oligosaccharide in malignant tumors and composition that contains it
09/28/2010CA2285746C Osteoprotegerin binding proteins and receptors
09/28/2010CA2270400C Mutant penicillin g acylases
09/28/2010CA2235866C Methods of treating established colitis using antibodies against il-12
09/28/2010CA2208783C Methods for producing immunoglobulins containing protection proteins in plants and their use
09/28/2010CA2188017C Cardiotrophin and uses therefor
09/28/2010CA2153494C Novel parasitic helminth proteins
09/27/2010CA2660622A1 Rig-i mutations and uses thereof in diagnostic and therapeutic virus-dependent immune applications
09/25/2010CA2697851A1 Composition and method for modulating plant transformation
09/25/2010CA2697848A1 Composition and method for modulating plant transformation
09/23/2010WO2010108183A1 Polypeptide expression in ciliates
09/23/2010WO2010108126A2 Reprogramming compositions and methods of using the same
09/23/2010WO2010108114A2 Polyunsaturated fatty acid synthase nucleic acid molecules and polypeptides, compositions, and methods of making and uses thereof
09/23/2010WO2010108108A2 Polyamine derivatives
09/23/2010WO2010108013A1 Compositions and methods for treating asthma and other lung diseases
09/23/2010WO2010107958A1 RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/23/2010WO2010107957A2 RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/23/2010WO2010107955A2 RNA INTERFERENCE MEDIATED INHIBITION OF BTB AND CNC HOMOLOGY 1, BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR 1 (BACH 1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) SEQUENCE LISTING
09/23/2010WO2010107952A2 RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/23/2010WO2010107946A2 Use of thermostable endonucleases for generating reporter molecules
09/23/2010WO2010107825A2 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
09/23/2010WO2010107740A2 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1
09/23/2010WO2010107733A2 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2
09/23/2010WO2010107716A2 Abscription based molecular detection
09/23/2010WO2010107644A2 Variant endoglucanases and related polynucleotides
09/23/2010WO2010107639A2 Isolation and characterization of novel green fluorescent proteins from copepods
09/23/2010WO2010107415A1 Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
09/23/2010WO2010107405A1 Method for producing peptides which specifically recognize cells of particular types and can be used for therapeutic purposes
09/23/2010WO2010107400A1 Genetically modified animal and method of obtaining the same
09/23/2010WO2010107397A1 Modulators of apoptosis and the uses thereof
09/23/2010WO2010107310A1 Novel cellulose and ligno-cellulose active proteins
09/23/2010WO2010107303A2 New fungal production system
09/23/2010WO2010107292A1 In vitro method for the detection of candida glabrata, diagnostic kit and use thereof
09/23/2010WO2010107126A1 Method for preventing or inhibiting infection of plant by microorganisms, and plant having resistance against infection by microorganisms
09/23/2010WO2010107116A1 Hla-a24-binding cancer antigen peptide derived from sox2
09/23/2010WO2010107113A1 Retroelement polymorphism detection method
09/23/2010WO2010107112A1 Method for preventing reduction in activity of enzyme during drying
09/23/2010WO2010107110A1 Antibody constant region variant
09/23/2010WO2010107109A1 Antibody constant region variant
09/23/2010WO2010107090A1 Parkinson's disease model mouse, process for producing the mouse, and screening method and evaluation method for therapeutic agent for parkinson's disease each using the mouse
09/23/2010WO2010107070A1 NOVEL ACETYL-CoA CARBOXYLASE